Today, the U.S. Food and Drug Administration expanded the approval of the COVID-19 treatment Veklury (remdesivir) to include pediatric patients 28 days of age and older weighing at least 3 kilograms (about 7 pounds) with positive results of direct SARS-CoV-2 viral testing, who are: Hospitalized, or Not hospitalized and have […]
Read More
Background Protection afforded from prior disease among patients with coronavirus disease 2019 (COVID-19) infection is unknown. If infection provides substantial long-lasting immunity, it may be appropriate to reconsider vaccination distribution. Methods This retrospective cohort study of 1 health system included 150,325 patients tested for COVID-19 infection via polymerase chain reaction […]
Read More
Dos estudios preliminares publicados este sábado ofrecen más evidencia de que el coronavirus se originó en animales y se propagó a los humanos a fines de 2019 en el mercado de mariscos de Huanan, en Wuhan, China. Uno de los estudios –ninguno de los cuales ha sido revisado por pares ni […]
Read More
El Shenzhen Rhegen Biotechnology Co. Ltd de la República Popular China ha publicado en preprint los resultados de una vacuna frente a la COVID-19 de ARN mensajero en forma liofilizada termoestable envuelto en nanopartículas lipídicas que podría almacenarse a temperatura ambiente durante largos periodos de tiempo. En concreto, presenta resultados de tres vacunas dirigidas […]
Read More
What is already known about this topic? In preauthorization trials, adverse reactions were reported less frequently following a homologous COVID-19 mRNA vaccine booster dose than after receipt of the second primary dose. What is added by this report? Review of surveillance data found that local and systemic reactions were less […]
Read More
A medida que la variante ómicron del nuevo coronavirus se propaga como un reguero de pólvora en Estados Unidos, es probable que casi todos estén expuestos a la cepa, pero a las personas vacunadas les irá mejor, dijo el martes el principal experto en enfermedades infecciosas del país. “Ómicron, con su grado […]
Read More
The Centers for Disease Control and Prevention (CDC) has updated its recommendations for the Pfizer COVID-19 vaccine to expand the use of a single booster dose to 12- to 15-year-olds. The Food and Drug Administration amended its emergency use authorization earlier this week. “Everyone at age 12 and up is approved for a booster after they’ve […]
Read More
Why stop at just SARS-CoV-2? Vaccines in development aim to protect against many coronaviruses at once. In 2017, three leading vaccine researchers submitted a grant application with an ambitious goal. At the time, no one had proved a vaccine could stop even a single beta coronavirus—the notorious viral group then […]
Read More
Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUA) for both the Moderna and Pfizer-BioNTech COVID-19 vaccines authorizing use of a single booster dose for all individuals 18 years of age and older after completion of primary vaccination with any FDA-authorized or approved COVID-19 vaccine. The […]
Read More
A federal judge overruled Texas Gov. Greg Abbott’s ban on mask mandates in schools, opening up the ability for school districts to set their own rules. US District Court Judge Lee Yeakel said the order violated the 1990 Americans with Disabilities Act because it hindered access to public education and […]
Read More